| Intrinsic Valuation of: GLAXO | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 54 | Market Cap | ₹574B | |||||
| 2021 | - | - (-) | P/E Ratio | 62 | Total Asset | ₹41B | |||||
| 2022 | ₹8B | - (-) | Net Income | ₹9B | Total Debt | ₹0 | |||||
| 2023 | ₹4B | -43.3% (-42.6%) | EBITDA | ₹13B | Total Liab | ₹22B | |||||
| 2024 | ₹6B | 25.1% (16.9%) | Opr Margin | 0.30 | Debt/Equity | - | |||||
| 2025 | ₹13B | 129.7% (111.6%) | PreTax Margin | 29.59 | BV/Share | 114 | |||||
| 5Y Average FCF | ₹8B | 37.2% (28.6%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | ₹16B | MBG Intrinsic Value | ₹486 | ||||||||
| 2027 | ₹20B | ||||||||||
| 2028 | ₹25B | ||||||||||
| 2029 | ₹31B | ||||||||||
| 2030 | ₹39B | ||||||||||
| 2031 | ₹48B | ||||||||||
| Terminal Value | ₹1,003B | Net Worth/Share | ₹115 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹786B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹5B | ₹4,672 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹0 | WACC | 7.3% | 4,066 | 4,388 | 4,777 | 5,255 | 5,858 | |||
| Equity Value | ₹791B | 7.4% | 4,028 | 4,344 | 4,724 | 5,191 | 5,778 | ||||
| Shares Outstanding | 169,406,000 | 7.4% | 3,991 | 4,300 | 4,672 | 5,128 | 5,700 | ||||
| 7.9% | 3,650 | 3,905 | 4,207 | 4,570 | 5,016 | ||||||
| DCF Intrinsic Value | ₹4,672 | 8.4% | 3,358 | 3,572 | 3,821 | 4,116 | 4,471 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||